Please use this identifier to cite or link to this item:
|Title:||Substituted borosilicate glasses with improved osteogenic capacity for bone tissue engineering|
|Author(s):||Fernandes, João S.|
Pires, R. A.
Hatton, Paul V.
Reis, R. L.
|Publisher:||Mary Ann Liebert Inc.|
|Citation:||Fernandes J. S., Gentile P., Crawford A., Pires R. A., Hatton P. V., Reis R. L. Substituted Borosilicate Glasses with Improved Osteogenic Capacity for Bone Tissue Engineering, Tissue Engineering, doi:10.1089/ten.TEA.2016.0386, 2017.|
|Abstract(s):||Borosilicate bioactive glasses (BBGs) have shown capacity to improve the new bone formation when compared to silicate bioactive glasses. Herein, we assessed the capacity of BBGs to induce the osteogenic differentiation of bone marrow mesenchymal stem cells (BM-MSCs), as a function of their substituted divalent cations (Mg2+, Ca2+, Sr2+). To this purpose, we synthesised BBG particles by melt quench. The cell viability, proliferation and morphology, (i.e. PrestoBlueÂ®, PicroGreenÂ®, and DAPI and Phalloidin stainings, respectively) as well as protein expression (of ALP, osteopontin and osteocalcin) of BM-MSCs in contact with the BBGs were evaluated for 21 days. We observed an enhanced expression of bone-specific proteins (ALP, OP and OC) and high mineralisation of BM-MSCs under BBG-Mg and BBGâ Sr conditioned osteogenic media for concentrations of 20 and 50 mg/mL with low cytotoxic effects. Moreover, BBG-Sr at a concentration of 50 mg/mL was able to increase the mineralisation and expression of bone-specific proteins even under basal media conditions. These results indicated that the proposed BBGs improved the osteogenic differentiation of BM-MSCs, showing therefore have great potential for the regeneration of bone tissue.|
|Appears in Collections:||3B’s - Artigos em revistas/Papers in scientific journals|
Files in This Item:
|18891-JoãoS.Fernandes_2016.pdf||2,31 MB||Adobe PDF||View/Open|